Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Molecule2Market is an Australian boutique contract research organization (CRO) providing comprehensive consulting and operational services to pharmaceutical, biotechnology, and medical device companies. The company specializes in supporting clinical trials in Australia and the Asia-Pacific region with expertise spanning project feasibility, site selection, study start-up, project management, monitoring, regulatory affairs, quality assurance/auditing, data management/statistics, medical writing/monitoring, local study sponsorships and R&D tax incentive applications. Their team consists of highly experienced professionals with 15–20+ years each in the industry. They do not develop their own therapeutics or have proprietary clinical results but enable client success across all phases of drug/device development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Molecule2Market.